Thalidomide for Multiple Myeloma

NCT00038233 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Thalidomide

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]